Oligomeric amyloid β preferentially targets neuronal and not glial mitochondrial-encoded mRNAs

Diego Mastroeni, Jennifer Nolz, Omar Khdour, Shobana Sekar, Elaine Delvaux, Lori Cuyugan, Winnie S. Liang, Sidney Hecht, Paul Coleman

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: Our laboratories have demonstrated that accumulation of oligomeric amyloid β (OAβ) in neurons is an essential step leading to OAβ-mediated mitochondrial dysfunction. Methods: Alzheimer's disease (AD) and matching control hippocampal neurons, astrocytes, and microglia were isolated by laser-captured microdissection from the same subjects, followed by whole-transcriptome sequencing. Complementary in vitro work was performed in OAβ-treated differentiated SH-SY5Y, followed by the use of a novel CoQ10 analogue for protection. This compound is believed to be effective both in suppressing reactive oxygen species and also functioning in mitochondrial electron transport. Results: We report decreases in the same mitochondrial-encoded mRNAs in Alzheimer's disease laser-captured CA1 neurons and in OAβ-treated SH-SY5Y cells, but not in laser-captured microglia and astrocytes. Pretreatment with a novel CoQ10 analogue, protects neuronal mitochondria from OAβ-induced mitochondrial changes. Discussion: Similarity of expression changes in neurons from Alzheimer's disease brain and neuronal cells treated with OAβ, and the effect of a CoQ10 analogue on the latter, suggests a pretreatment option to prevent OAβ toxicity, long before the damage is apparent.

Original languageEnglish (US)
JournalAlzheimer's and Dementia
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

coenzyme Q10
Amyloid
Neuroglia
Neurons
Alzheimer Disease
Lasers
Microglia
Astrocytes
Microdissection
Electron Transport
mitochondrial messenger RNA
Transcriptome
Reactive Oxygen Species
Mitochondria
Brain

Keywords

  • Alzheimer's disease
  • Laser capture microdissection
  • Mitochondria
  • Multifunctional radical quencher
  • Oligomeric amyloid β

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

Oligomeric amyloid β preferentially targets neuronal and not glial mitochondrial-encoded mRNAs. / Mastroeni, Diego; Nolz, Jennifer; Khdour, Omar; Sekar, Shobana; Delvaux, Elaine; Cuyugan, Lori; Liang, Winnie S.; Hecht, Sidney; Coleman, Paul.

In: Alzheimer's and Dementia, 01.01.2018.

Research output: Contribution to journalArticle

@article{4a2af392603d44ef80a02f1d083867b0,
title = "Oligomeric amyloid β preferentially targets neuronal and not glial mitochondrial-encoded mRNAs",
abstract = "Introduction: Our laboratories have demonstrated that accumulation of oligomeric amyloid β (OAβ) in neurons is an essential step leading to OAβ-mediated mitochondrial dysfunction. Methods: Alzheimer's disease (AD) and matching control hippocampal neurons, astrocytes, and microglia were isolated by laser-captured microdissection from the same subjects, followed by whole-transcriptome sequencing. Complementary in vitro work was performed in OAβ-treated differentiated SH-SY5Y, followed by the use of a novel CoQ10 analogue for protection. This compound is believed to be effective both in suppressing reactive oxygen species and also functioning in mitochondrial electron transport. Results: We report decreases in the same mitochondrial-encoded mRNAs in Alzheimer's disease laser-captured CA1 neurons and in OAβ-treated SH-SY5Y cells, but not in laser-captured microglia and astrocytes. Pretreatment with a novel CoQ10 analogue, protects neuronal mitochondria from OAβ-induced mitochondrial changes. Discussion: Similarity of expression changes in neurons from Alzheimer's disease brain and neuronal cells treated with OAβ, and the effect of a CoQ10 analogue on the latter, suggests a pretreatment option to prevent OAβ toxicity, long before the damage is apparent.",
keywords = "Alzheimer's disease, Laser capture microdissection, Mitochondria, Multifunctional radical quencher, Oligomeric amyloid β",
author = "Diego Mastroeni and Jennifer Nolz and Omar Khdour and Shobana Sekar and Elaine Delvaux and Lori Cuyugan and Liang, {Winnie S.} and Sidney Hecht and Paul Coleman",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jalz.2017.12.005",
language = "English (US)",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Oligomeric amyloid β preferentially targets neuronal and not glial mitochondrial-encoded mRNAs

AU - Mastroeni, Diego

AU - Nolz, Jennifer

AU - Khdour, Omar

AU - Sekar, Shobana

AU - Delvaux, Elaine

AU - Cuyugan, Lori

AU - Liang, Winnie S.

AU - Hecht, Sidney

AU - Coleman, Paul

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Introduction: Our laboratories have demonstrated that accumulation of oligomeric amyloid β (OAβ) in neurons is an essential step leading to OAβ-mediated mitochondrial dysfunction. Methods: Alzheimer's disease (AD) and matching control hippocampal neurons, astrocytes, and microglia were isolated by laser-captured microdissection from the same subjects, followed by whole-transcriptome sequencing. Complementary in vitro work was performed in OAβ-treated differentiated SH-SY5Y, followed by the use of a novel CoQ10 analogue for protection. This compound is believed to be effective both in suppressing reactive oxygen species and also functioning in mitochondrial electron transport. Results: We report decreases in the same mitochondrial-encoded mRNAs in Alzheimer's disease laser-captured CA1 neurons and in OAβ-treated SH-SY5Y cells, but not in laser-captured microglia and astrocytes. Pretreatment with a novel CoQ10 analogue, protects neuronal mitochondria from OAβ-induced mitochondrial changes. Discussion: Similarity of expression changes in neurons from Alzheimer's disease brain and neuronal cells treated with OAβ, and the effect of a CoQ10 analogue on the latter, suggests a pretreatment option to prevent OAβ toxicity, long before the damage is apparent.

AB - Introduction: Our laboratories have demonstrated that accumulation of oligomeric amyloid β (OAβ) in neurons is an essential step leading to OAβ-mediated mitochondrial dysfunction. Methods: Alzheimer's disease (AD) and matching control hippocampal neurons, astrocytes, and microglia were isolated by laser-captured microdissection from the same subjects, followed by whole-transcriptome sequencing. Complementary in vitro work was performed in OAβ-treated differentiated SH-SY5Y, followed by the use of a novel CoQ10 analogue for protection. This compound is believed to be effective both in suppressing reactive oxygen species and also functioning in mitochondrial electron transport. Results: We report decreases in the same mitochondrial-encoded mRNAs in Alzheimer's disease laser-captured CA1 neurons and in OAβ-treated SH-SY5Y cells, but not in laser-captured microglia and astrocytes. Pretreatment with a novel CoQ10 analogue, protects neuronal mitochondria from OAβ-induced mitochondrial changes. Discussion: Similarity of expression changes in neurons from Alzheimer's disease brain and neuronal cells treated with OAβ, and the effect of a CoQ10 analogue on the latter, suggests a pretreatment option to prevent OAβ toxicity, long before the damage is apparent.

KW - Alzheimer's disease

KW - Laser capture microdissection

KW - Mitochondria

KW - Multifunctional radical quencher

KW - Oligomeric amyloid β

UR - http://www.scopus.com/inward/record.url?scp=85040795883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040795883&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2017.12.005

DO - 10.1016/j.jalz.2017.12.005

M3 - Article

C2 - 29396107

AN - SCOPUS:85040795883

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

ER -